| http://dbpedia.org/ontology/abstract
|
Astellas Institute for Regenerative Medici … Astellas Institute for Regenerative Medicine adalah anak perusahaan Astellas Pharma yang berlokasi di Marlborough, Massachusetts, Amerika Serikat, yang bergerak di pengembangan terapi sel punca dengan fokus penyakit-penyakit yang menyebabkan kebutaan. Sebelum dibeli Astellas dengan harga $379 juta pada Februari 2016, perusahaan ini didirikan dengan nama Advanced Cell Technology pada 1994, lalu berganti nama menjadi Ocata Therapeutics pada November 2014.adi Ocata Therapeutics pada November 2014.
, Astellas Institute for Regenerative Medici … Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. In February 2016 Ocata was acquired by Astellas for $379 million USD.acquired by Astellas for $379 million USD.
|
| http://dbpedia.org/ontology/foundingYear
|
1994
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Marlborough%2C_MA +
|
| http://dbpedia.org/ontology/wikiPageID
|
13411300
|
| http://dbpedia.org/ontology/wikiPageLength
|
10229
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1051614407
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Stem_cell_therapy +
, http://dbpedia.org/resource/Embryonic_stem_cells +
, http://dbpedia.org/resource/Macular_degeneration +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Geron_Corporation +
, http://dbpedia.org/resource/Investigational_New_Drug +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Robert_Lanza +
, http://dbpedia.org/resource/BioTime +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1994 +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Marlborough%2C_MA +
, http://dbpedia.org/resource/Retinal_pigment_epithelium +
, http://dbpedia.org/resource/Stargardt_disease +
, http://dbpedia.org/resource/Somatic_cell_nuclear_transfer +
, http://dbpedia.org/resource/Visual_impairment +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Astellas_Pharma +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Marlborough%2C_Massachusetts +
, http://dbpedia.org/resource/Macular_Degeneration +
, http://dbpedia.org/resource/Michael_D._West +
, http://dbpedia.org/resource/Stem_cell_controversy +
, http://dbpedia.org/resource/Europe +
, http://dbpedia.org/resource/Regenerative_medicine +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Category:Astellas_Pharma +
, http://dbpedia.org/resource/Stem_cell +
, http://dbpedia.org/resource/NASDAQ +
, http://dbpedia.org/resource/Category:Stem_cells +
|
| http://dbpedia.org/property/foundation
|
1994
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Marlborough%2C_MA +
|
| http://dbpedia.org/property/products
|
Stem cell therapies for macular degeneration , retinis pigmentosa, glaucoma and corneal blindness
|
| http://dbpedia.org/property/type
|
Subsidiary
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Official_website +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Stem_cells +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Astellas_Pharma +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1994 +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/131724199 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Astellas_Institute_for_Regenerative_Medicine?oldid=1051614407&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Astellas_Institute_for_Regenerative_Medicine +
|
| owl:sameAs |
http://id.dbpedia.org/resource/Astellas_Institute_for_Regenerative_Medicine +
, http://viaf.org/viaf/131724199 +
, http://ms.dbpedia.org/resource/Astellas_Institute_for_Regenerative_Medicine +
, http://dbpedia.org/resource/Astellas_Institute_for_Regenerative_Medicine +
, https://global.dbpedia.org/id/4Lkxg +
, http://www.wikidata.org/entity/Q4686139 +
|
| rdf:type |
http://schema.org/Organization +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
|
| rdfs:comment |
Astellas Institute for Regenerative Medici … Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. In February 2016 Ocata was acquired by Astellas for $379 million USD.acquired by Astellas for $379 million USD.
, Astellas Institute for Regenerative Medici … Astellas Institute for Regenerative Medicine adalah anak perusahaan Astellas Pharma yang berlokasi di Marlborough, Massachusetts, Amerika Serikat, yang bergerak di pengembangan terapi sel punca dengan fokus penyakit-penyakit yang menyebabkan kebutaan. Sebelum dibeli Astellas dengan harga $379 juta pada Februari 2016, perusahaan ini didirikan dengan nama Advanced Cell Technology pada 1994, lalu berganti nama menjadi Ocata Therapeutics pada November 2014.adi Ocata Therapeutics pada November 2014.
|
| rdfs:label |
Astellas Institute for Regenerative Medicine
|
